Services search (in the department)
Illness | Number of cases |
---|---|
Lymphoid leukaemia - Acute lymphoblastic leukemia not having achieved remission (C91.00) | 189 |
Non-follicular lymphoma (C83.5) | 88 |
Myeloid leukaemia - Acute myeloblastic leukemia not having achieved remission (C92.00) | 73 |
Malignant neoplasm of kidney except renal pelvis (C64) | 68 |
Malignant neoplasm of peripheral nerves and autonomic nervous system - Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system (C47.8) | 42 |
Malignant neoplasm of peripheral nerves and autonomic nervous system - Malignant neoplasm of peripheral nerves of abdomen (C47.4) | 34 |
Hodgkin lymphoma (C81.2) | 30 |
Peripheral and cutaneous T-cell lymphomas (C84.4) | 28 |
Malignant neoplasm of bone and articular cartilage of limbs (C40.2) | 27 |
Malignant neoplasm of bone and articular cartilage of limbs (C40.0) | 21 |
Treatment | Number |
---|---|
(9-985.0) | 456 |
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11) | 308 |
(9-984.b) | 239 |
(9-984.7) | 183 |
Treatment by injecting a medicine into an organ or tissue, or removal of excess fluid (effusion) e.g. from the joints (8-020.x) | 175 |
(9-984.8) | 129 |
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0) | 99 |
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.12) | 89 |
Treatment by the targeted insertion of a needle into the brain, spinal cord or the eye with subsequent administration or removal of substances, e.g. fluid (8-151.4) | 74 |
Instillation into a body cavity and locally restricted treatment with chemotherapy drugs or agents that influence the immune system (8-541.0) | 66 |
No. | Explanation |
---|---|
CQ05 | |
CQ02 |
Number | Group |
---|---|
87 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
19 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
15 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
Job | Explanation |
---|---|
Student training (clinical traineeship / internship year) | |
Lectureships / teaching posts at colleges and universities | |
Lectureships / teaching posts at universities of applied sciences | |
Doctoral supervision | |
Project-related cooperation with colleges and universities | |
Editors of scientific journals/textbooks | |
Participation in multi-centre phase III/IV studies | |
Participation in multi-centre Phase I/II studies |
No. | Training in other healing professions | Comment |
---|---|---|
HB20 | Nursing professional B. Sc. | |
HB19 | Nursing professionals | |
HB07 | Surgical technical assistant (m/f) | |
HB12 | Medical technical laboratory assistant (MTLA) (m/f) | |
HB10 | Midwife (m/f) |
Andrea Halberschmidt
Qualitätsmanagerin
Phone:
0911
-3340-5058
Mail:
ed.oenokaid@tdimhcsreblah.aerdna
Andrea Halberschmidt
Qualitätsmanagerin
Phone:
0911
-3340-5058
Mail:
ed.oenokaid@tdimhcsreblah.aerdna
Prof. Dr. Michael Kranzfelder
Chefarzt Allgemein- und Viszeralchirurgie
Phone:
0911
-3340-2600
Mail:
ed.oenokaid@redlefznark.leahciM
Mag. pharm. Wilhelm Bouhon
externer Apotheker , Kooperationspartner Mohren Apotheke
Phone:
0911
-206-330
Mail:
gro.ekehtopA-nerhoM@nohuoB.mlehliW